HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVS Standards: Another Step In Supplement Industry Transparency Evolution

This article was originally published in The Rose Sheet

Executive Summary

CVS Pharmacy is developing standards, including third-party tests, for vitamins and supplements sold in its stores. Targeted for implementation by 2019, the standards are part of a health care-focused effort in which the firm will expand its lineup of vitamins and supplements.

You may also be interested in...



CVS Trims 7% Of Supplements From Its Shelves In 'Tested To Be Trusted' Program

CVS implemented “Tested to be Trusted” third-party program for supplements six months ahead of schedule, reducing products at store shelves 7%. National drug chain confirms it will roll out more than 300 health and wellness products across six additional categories.

SIDI Supplier Protocol Update Adds To Burgeoning Self-Regulation Library

SIDI's draft protocol update incorporates changes to guide compliance with rules established by FSMA relevant to supplement firms and adds information on economically motivated adulteration and determining whether dietary ingredients are grandfathered as compliant under DSHEA.

Supplement OWL Registry Counts On Peer Pressure To Spur Use

CRN-organized Supplement OWL launches with nearly 2,600 labels included and adds almost 500 more in its first week, though a much larger total is needed to offer drug store chains and other retailers access a broader perspective of products available in the US.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS109216

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel